Pharmafile Logo

Value-Based Cancer Care

- PMLiVE

IQWiG unimpressed with Cosentyx in two new indications

Concludes Novartis drug has no added benefit in ankylosing spondylitis or psoriatic arthritis

- PMLiVE

Applying real-world evidence to orphan drugs

How to prove pharma’s innovative treatments really can bring about positive outcomes

A rough guide to… advisory boards

Our intrepid writers take us on a journey through advisory boards and show that pre-trip planning is the pathway to perfection

- PMLiVE

Micreos appoints chief medical officer

Dr Johan Frieling brings experience from Bayer and Genzyme

- PMLiVE

Valeant begins search for new CEO

Michael Pearson will continue in the role until his successor is appointed

There’s never a dull moment at Lucid Group

Andrea Hamlin, Angela Tye-Galichet, Emma Herring and Ify Onyeaso were all treated to a fabulous lunch with the Lucid Co-Founders, Dennis O’Brien and Jan Steele in celebration of their 5...

Lucid Group Communications Limited

Lucid Group support local charity event

Lucid Group donated 75 Easter chocolate bunnies to a group of local school children organising an Easter Egg Hunt who were raising funds for Médecins Sans Frontières. The egg hunt...

Lucid Group Communications Limited

- PMLiVE

Apple creates open source personal health app software

Will release CareKit framework later in the Spring 

- PMLiVE

Amgen and UCB’s romosozumab hits goals in male osteoporosis

Firms will discuss data with regulators before planning a new male licence application

Novartis building

NICE backs Novartis’ Entresto for heart failure

But approves narrower indication than has been authorised by Scotland's SMC

- PMLiVE

Nicki Muir moves from LEC Healthcare to The Purple Agency

She joins as account director of its healthcare team

- PMLiVE

Using social data to see patients more clearly

A new dawn is approaching in healthcare and drug safety

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links